Hosted by IDTechEx
Truly Global Daily News Interpreted by Experts
HomeEventsReportsTVCareersAbout UsSign-up or LoginIDTechExTwitterLinkedInGoogle+YoutubeRSSForward To Friend

Pharmaceutical

Dozens of new genes that create T cell-resistant cancer discovered

Dozens of new genes that create T cell-resistant cancer discovered

Aug 11, 2017 United States
To better understand why some cancers are resistant to immunotherapy, researchers collaborated on a large-scale CRISPR cancer study.
Upconverted light has a bright future

Upconverted light has a bright future

Jul 25, 2017 United States
A professor's method to "upconvert" light could make solar cells more efficient and disease-targeting nanoparticles more effective.
Personalized cancer vaccine

Personalized cancer vaccine

Jul 14, 2017 United States
A personal cancer treatment vaccine that targets distinctive "neoantigens" on tumor cells has been shown to stimulate a potent, safe, and highly specific immune anti-tumor response in melanoma patients.
Strategic drug discovery collaboration

Strategic drug discovery collaboration

Jul 10, 2017 United Kingdom
Exscientia has entered into a strategic drug discovery collaboration with GlaxoSmithKline.
Nanoparticles breathe new life into doxorubicin cancer treatment

Nanoparticles breathe new life into doxorubicin cancer treatment

Jun 16, 2017 Worldwide
Doxorubicin, originally daunorubicin, is the result of a simultaneous discovery event in the 1950's between researchers in France and Italy. The molecule, a well-known anti-cancer drug used for a variety of indications ranging from acute lymphocytic leukemia to breast cancer, was approved for use in the United States in 1974.